130 related articles for article (PubMed ID: 35191604)
1. ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway.
Lv C; Yang H; Yu J; Dai X
Environ Toxicol; 2022 Jun; 37(6):1423-1431. PubMed ID: 35191604
[TBL] [Abstract][Full Text] [Related]
2. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
[TBL] [Abstract][Full Text] [Related]
3. UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
Lu ZN; Song J; Sun TH; Sun G
Chin Med J (Engl); 2021 Oct; 134(20):2465-2474. PubMed ID: 34620747
[TBL] [Abstract][Full Text] [Related]
4. MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway.
Li Z; Li C; Wu Q; Tu Y; Wang C; Yu X; Li B; Wang Z; Sun S; Sun S
Cell Death Dis; 2021 Jan; 12(1):97. PubMed ID: 33462219
[TBL] [Abstract][Full Text] [Related]
5. ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway.
Cui Y; Liang S; Zhang S; Zhang C; Zhao Y; Wu D; Wang J; Song R; Wang J; Yin D; Liu Y; Pan S; Liu X; Wang Y; Han J; Meng F; Zhang B; Guo H; Lu Z; Liu L
J Exp Clin Cancer Res; 2020 May; 39(1):90. PubMed ID: 32430024
[TBL] [Abstract][Full Text] [Related]
6. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
Yang T; Xiao Y; Liu S; Luo F; Tang D; Yu Y; Xie Y
Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
[TBL] [Abstract][Full Text] [Related]
7. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
8. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
9. Identification and Verification of Key Tumor Genes Associated with Diagnosis and Prognosis of Breast Cancer Based on Bioinformatics Analysis.
Yu F; Pan XJ; Luo J
Dis Markers; 2022; 2022():9041466. PubMed ID: 35686034
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMPK α2 inhibits airway smooth muscle cells proliferation.
Liu L; Pan Y; Song Y; Su X; Ke R; Yang L; Gao L; Li M
Eur J Pharmacol; 2016 Nov; 791():235-243. PubMed ID: 27600020
[TBL] [Abstract][Full Text] [Related]
12. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
Shaw RJ
Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
[TBL] [Abstract][Full Text] [Related]
13. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
Hwang YJ; Park JH; Cho DH
J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519
[TBL] [Abstract][Full Text] [Related]
14. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
15. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
16. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.
Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR
Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344
[TBL] [Abstract][Full Text] [Related]
17. 17β-Estradiol Induces Mitophagy Upregulation to Protect Chondrocytes
Mei R; Lou P; You G; Jiang T; Yu X; Guo L
Front Endocrinol (Lausanne); 2020; 11():615250. PubMed ID: 33613450
[TBL] [Abstract][Full Text] [Related]
18. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
19. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells.
Appuhamy JA; Nayananjalie WA; England EM; Gerrard DE; Akers RM; Hanigan MD
J Dairy Sci; 2014; 97(1):419-29. PubMed ID: 24183687
[TBL] [Abstract][Full Text] [Related]
20. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
